Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LSS | P48449 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL465309 | 1.00 | TSHR (0.46) | TSHRALDH1A1LSSALOX15LMNA | |
| SCHEMBL465310 | 1.00 | TSHR (0.46) | TSHRALDH1A1LSSALOX15LMNA | |
| SCHEMBL849059 | 0.95 | TSHR (0.48) | TSHRALDH1A1LSSALOX15LMNA | |
| SCHEMBL8072337 | 0.95 | TSHR (0.48) | TSHRALDH1A1LSSALOX15LMNA | |
| SCHEMBL849060 | 0.95 | TSHR (0.48) | TSHRALDH1A1LSSALOX15LMNA | |
| SCHEMBL848895 | 0.93 | TSHR (0.52) | TSHRALDH1A1LSSLMNAABCC4 | |
| SCHEMBL848894 | 0.93 | TSHR (0.52) | TSHRALDH1A1LSSLMNAABCC4 | |
| SCHEMBL9461009 | 0.87 | TSHR (0.35) | TSHRALDH1A1LMNAMAPT | |
| SCHEMBL848542 | 0.85 | — | — | |
| SCHEMBL848543 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882283-A1 | ETHYLENE-COPOLYMERS AND CATALYST MIXTURE FOR MAKING ETHYLENE COPOLYMERS | Arlanxeo Netherlands B.V. (NL) | 2021-09-22 | — | — | EP | claimed |
| US-9382344-B2 | Mitigation of catalyst inhibition in olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-07-05 | — | — | US | claimed |
| EP-3013867-A1 | MITIGATION OF CATALYST INHIBITION IN OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2016-05-04 | — | — | EP | claimed |
| WO-2014209813-A1 | MITIGATION OF CATALYST INHIBITION IN OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-12-31 | — | — | WO | claimed |
| US-20140378732-A1 | Mitigation of Catalyst Inhibition in Olefin Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-12-25 | — | — | US | claimed |
| EP-1346824-B1 | Compositions and methods for selectively cross-linking films and film articles resulting therefrom | CRYOVAC INC (US) | 2009-05-13 | — | — | EP | claimed |
| EP-1016689-B1 | Olefin thermoplastic elastomer compositions | MITSUI CHEMICALS INC (JP) | 2007-03-07 | — | — | EP | claimed |
| EP-0889780-B1 | COMPOSITIONS AND METHODS FOR SELECTIVELY CROSS-LINKING FILMS AND IMPROVED FILM ARTICLES RESULTING THEREFROM | CRYOVAC INC (US) | 2004-07-14 | — | — | EP | claimed |
| EP-1346824-A2 | Compositions and methods for selectively cross-linking films and film articles resulting therefrom | Cryovac, Inc. (US) | 2003-09-24 | — | — | EP | claimed |
| EP-0889780-A4 | COMPOSITIONS AND METHODS FOR SELECTIVELY CROSS-LINKING FILMS AND IMPROVED FILM ARTICLES RESULTING THEREFROM | CRYOVAC INC (US) | 2000-10-04 | — | — | EP | claimed |
| US-5993922-A | MULTILAYER FILM CONTAINING AT LEAST ONE LAYER CONTAINING POLYMER CROSSLINKING ENHANCER COMPOSITION WHEREIN EACH OF AT LEAST ONE LAYER IS CROSSLINKED TO A GREATER DEGREE THAN ONE OTHER LAYER; FOOD PACKAGING | CRYOVAC, INC. (US) | 1999-11-30 | — | — | US | claimed |
| EP-0889780-A1 | COMPOSITIONS AND METHODS FOR SELECTIVELY CROSS-LINKING FILMS AND IMPROVED FILM ARTICLES RESULTING THEREFROM | Cryovac, Inc. (US) | 1999-01-13 | — | — | EP | claimed |
| WO-1997036741-A9 | COMPOSITIONS AND METHODS FOR SELECTIVELY CROSS-LINKING FILMS AND IMPROVED FILM ARTICLES RESULTING THEREFROM | — | 1998-12-17 | — | — | WO | claimed |
| WO-1997036741-A1 | COMPOSITIONS AND METHODS FOR SELECTIVELY CROSS-LINKING FILMS AND IMPROVED FILM ARTICLES RESULTING THEREFROM | CRYOVAC, INC. (US) | 1997-10-09 | — | — | WO | claimed |
| EP-0506076-B1 | Polyphenylene ether/polyolefin resin composition | MITSUBISHI CHEM CORP (JP) | 1996-07-24 | — | — | EP | claimed |
| US-5418287-A | Impact strength, blend | MITSUBISHI PETROCHEMICAL COMPANY, LTD. (JP) | 1995-05-23 | — | — | US | claimed |
| EP-0506076-A2 | Polyphenylene ether/polyolefin resin composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-09-30 | — | — | EP | claimed |
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | ARLANXEO NETHERLANDS B.V. (NL) | 2026-02-24 | — | — | US | disclosed |
| EP-0452156-A2 | Solid titanium catalyst component for olefin polymerization, olefin polymerization catalyst, prepolymerized polyolefin-containing catalyst and method of olefin polymerization | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |
| EP-0423363-A1 | HIGHER $g(a)-OLEFIN COPOLYMER, METHOD OF PRODUCTION THEREOF, PRODUCT OF VULCANIZATION THEREOF, AND VULCANIZABLE RUBBER COMPOSITION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | EEF1D, COG7, CCND1 | TSHR 3104/4885ALDH1A1 3591/4885LSS 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.